Evidence map›Paper›PMID 25065939›Full record

ArticleNeoplasia (New York, N.Y.)2014

Immortalization of T-cells is accompanied by gradual changes in CpG methylation resulting in a profile resembling a subset of T-cell leukemias.

Sofie Degerman, Mattias Landfors, Jan Konrad Siwicki, John Revie, Magnus Borssén, Emma Evelönn, Erik Forestier, Krystyna H Chrzanowska, Patrik Rydén, W Nicol Keith and 1 more

Open access · goldAbstract read
In one paragraph

Article in Neoplasia (New York, N.Y.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. DNA methylation status defines clinicopathological parameters including survival for patients with clear cell renal cell carcinoma (ccRCC).Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Sofie DegermanDepartment of Medical Biosciences, Umeå University, SE-90185 Umeå, Sweden. Electronic address: sofie.degerman@medbio.umu.se.
Mattias LandforsDepartment of Medical Biosciences, Umeå University, SE-90185 Umeå, Sweden; Department of Mathematics and Mathematical Statistics, Umeå University, SE-90185 Umeå, Sweden.
Jan Konrad SiwickiDepartment of Immunology, Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, 02-781 Warsaw, Poland.
John RevieWolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, UK.
Magnus BorssénDepartment of Medical Biosciences, Umeå University, SE-90185 Umeå, Sweden.
Emma EvelönnDepartment of Medical Biosciences, Umeå University, SE-90185 Umeå, Sweden.
Erik ForestierDepartment of Medical Biosciences, Umeå University, SE-90185 Umeå, Sweden.
Krystyna H ChrzanowskaDepartment of Medical Genetics, Children's Memorial Health Institute, 04-730 Warsaw, Poland.
Patrik RydénDepartment of Mathematics and Mathematical Statistics, Umeå University, SE-90185 Umeå, Sweden; Computational Life Science Cluster, Umeå University, SE-90185 Umeå, Sweden.
W Nicol KeithWolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, UK.
Göran RoosDepartment of Medical Biosciences, Umeå University, SE-90185 Umeå, Sweden.
Umeå University · SEUniversity of Glasgow · GBChildren's Memorial Health Institute · PLThe Maria Sklodowska-Curie National Research Institute of Oncology · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We have previously described gene expression changes during spontaneous immortalization of T-cells, thereby identifying cellular processes important for cell growth crisis escape and unlimited proliferation. Here, we analyze the same model to investigate the role of genome-wide methylation in the immortalization process at different time points pre-crisis and post-crisis using high-resolution arrays. We show that over time in culture there is an overall accumulation of methylation alterations, with preferential increased methylation close to transcription start sites (TSSs), islands, and shore regions. Methylation and gene expression alterations did not correlate for the majority of genes, but for the fraction that correlated, gain of methylation close to TSS was associated with decreased gene expression. Interestingly, the pattern of CpG site methylation observed in immortal T-cell cultures was similar to clinical T-cell acute lymphoblastic leukemia (T-ALL) samples classified as CpG island methylator phenotype positive. These sites were highly overrepresented by polycomb target genes and involved in developmental, cell adhesion, and cell signaling processes. The presence of non-random methylation events in in vitro immortalized T-cell cultures and diagnostic T-ALL samples indicates altered methylation of CpG sites with a possible role in malignant hematopoiesis.

Indexed as

CpG IslandsDNA MethylationCells, CulturedCell Transformation, NeoplasticCluster AnalysisGene Expression ProfilingGene Expression Regulation, LeukemicGene Regulatory NetworksHumansLeukemia, T-CellReproducibility of ResultsT-Lymphocytes

Identifiers

PMID25065939
PMCPMC4198827
OpenAlexW2012534352

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.